Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
Espagne (1)
Policy
Musculoskeletal/Multiple Sclerosis (MS) (1)
Academic Medical Center/Hospital/Practice (3)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Representativeness of stakeholders
Health Technology Assessment (HTA) activities